About AMRN

Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Amarin's clinical program includes commitment to an ongoing outcomes study. Amarin's first product, Vascepa (icosapent ethyl) capsules, is a highly pure EPA omega-3 prescription product.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

AMRN is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 247.9 M 2.47865E+08 234 234 0.36% 0.00364184 1.8 M 1848050
UBIO Proshares UltraPro Nasdaq Biotechnology 31.1 M 3.10775E+07 228 228 0.21% 0.00211611 207 K 207242
ADRD Invesco BLDRS Developed Markets 100 ADR Index Fund 36.9 M 3.69E+07 84 84 0.14% 0.00142 52 K 52278
ADRU Invesco BLDRS Europe Select ADR Index Fund 12.8 M 1.28E+07 69 69 0.17% 0.00172 22 K 22014
IBB iShares Nasdaq Biotechnology Index Fund 8.2 B 8.24908E+09 222 222 0.79% 0.0079 65.7 M 6.56551E+07
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.0 B 2E+09 1,005 1005 0.05% 0.000478876 944 K 944303

Wait, Before You Leave...